Jonca Camille Bull MD
Jonca Bull, M.D., serves as consultant focused on drug development and regulatory considerations since May 2019. As a regulatory affairs authority with broad therapeutic expertise, she helps guide the strategic development and implementation of clinical trial protocols.
From 2017-2019, she served as Vice President of Regulatory Consulting within PPD Global Product Development and therapeutic director for Ophthalmology. She is a subject matter expert in advancing clinical trial diversity, bioethical considerations in clinical trials and for patient centricity and patient voice. Prior to joining PPD, Dr. Bull served as assistant commissioner at FDA with a focus on diverse populations and clinical trials; vice president for U.S./North American regulatory policy for Novartis Pharmaceuticals; and director of clinical regulatory policy for Genentech. From 1994 to 2005, Dr. Bull held various senior leadership roles with the FDA across various disease areas and programs. From 1982 to 1994 she cared for patients in a multi-specialty medical/surgical practice in the Washington metro area.
Dr. Bull holds an undergraduate degree from Princeton University, a medical degree from Duke University, and she did residencies in general medicine and ophthalmology at George Washington University Hospital in Washington, D.C., where she served as an assistant clinical professor. She is board certified and a fellow of the American Academy of Ophthalmology.
Susan Croushore has held 4 CEO healthcare positions, most recently as President and CEO Mercy Health System of Southeast Pennsylvania. Mercy, a member of Trinity Health, has three hospitals, a large Home Care Division, five PACE centers, a Physician Network/ CIN, ACO and Gateway, a joint venture insurance plan focused on Medicaid and special needs clients.
She also led The Christ Hospital and Health Network based in Cincinnati, Ohio where she transformed the organization from a system member hospital into an independent health system with top decile performance across all quality, safety and experience measures. Susan has also served as the CEO of Jeanes Hospital/Temple University Health System in Philadelphia as well as the President of St. Joseph’s Hospital in Lancaster, PA. She has extensive experience in both community hospital leadership as well as academic medical centers, including Hahnemann University and the Medical College of Pennsylvania. Croushore started her career as a Microbiologist and has a BS from Penn State University, MS from Thomas Jefferson University and Masters of Business Administration (MBA) from LaSalle University.
Susan has served on a number of Boards, including the Ohio Hospital Association Board, American Heart Association Great Rivers Affiliate, United Way Board, and Federal Reserve Bank of Cleveland - Cincinnati Division. Most recently, she has been a member of the Gateway Health Plan Board and Executive Committee, the American Hospital Association Region 2 Policy Board, the Hospital Association of Pennsylvania Board and the HSX Board, a health exchange collaborative. She has served as the national chair of the Volunteer Oversight Group of the American Heart Association and a board member of both the regional and local AHA boards.
Susan has been recognized by Modern Healthcare as one of the Top 25 Women in healthcare, as well as a finalist with Ernst & Young as Entrepreneur of the Year, the Cincinnati Chamber of Commerce Corporate Woman of the year and the Hospital Association of PA Grassroots champion of the Year. She has been a keynote speaker, educator, panelist and consultant.
Dima M. Qato, PharmD, MPH, PhD
Dima M. Qato, PharmD, MPH, PhD is a nationally-recognized pharmacist and pharmacoepidemiologist and is currently an Associate Professor in the Department of Pharmacy Systems, Outcomes and Policy at the University of Illinois College of Pharmacy. She has recently been selected as a National Academy of Medicine Pharmacy Fellow. Dr. Qato received her PharmD from UIC, an MPH from the Johns Hopkins School of Public Health and a PhD in Public Health from the University of Illinois School of Public Health.
Dr. Qato’s research focuses on access and safe use of medications in vulnerable populations in the United States and abroad. She utilizes population-based methods to better understand the underlying mechanisms responsible for the use, underuse and unsafe use of medications, how these patterns may influence health outcomes and health disparities, and what can be done from a community and policy perspective to address these growing public health problems.
Her work on polypharmacy, including drug-drug interactions, was awarded the 2017 American Society of Health System Pharmacists (ASHP) Literature Award in Drug Therapy Research. Dr. Qato’s research has received widespread media coverage including in The New York Times, NPR, PBS News, Washington Post, The Atlantic, CNN, BBC, and National Geographic and is funded by various agencies, including the National Institutes of Health and has also influenced local and national policy around medication access and safety.
Dr. Qato’s goal is to promote public accountability in ensuring access to, and safe use of, medications at the national, state and local levels. In an effort to achieve this goal, Dr. Qato is interested in incorporating polypharmacy and role of pharmacies in ongoing health care reform.
Todd Enders is a consultant and advisor to high-growth technology companies globally, helping with new category and market definition, product positioning and launch, and growth strategy.
From 2015-2018 he served as the VP of Product Marketing for Customer Service technology at Salesforce, and prior to that led the launch of their business intelligence product.
Prior to Salesforce, Todd led marketing and product marketing teams at Hedgeye, FirstRain, Primavera Software, and Evolve Software. He has been a product leader for BI applications at Oracle, and serves as a volunteer and occasional board member for multiple local organizations in his community of Moss Beach, California.
Dr. Sonia Lohiya Krishna
Dr. Sonia Lohiya Krishna is a board certified physician specializing in Child, Adolescent, and Adult Psychiatry, and Integrative Holistic Medicine. Born and raised in Newport Beach, she studied and trained at top institutions in southern California. She completed both her Psychiatry residency and her Child and Adolescent Psychiatry fellowship at the UCLA Semel Institute for Neuroscience and Human Behavior. She worked in a variety of centers including: academic hospitals, Veterans Affairs, integrated primary care clinics, and county facilities.
After moving to Austin in 2014, Dr. Krishna was faculty at UTMB, Texas A&M, and Dell Medical School where she supervised medical students, residents, and fellows during clinical rotations. She worked on the inpatient child and adolescent psychiatry unit at Seton Shoal Creek, the outpatient clinic at Texas Child Study Center, and consultation-liaison team at Dell Children’s Medical Center. She worked closely with the DCMC Foundation to fundraise the millions of dollars needed to create the state-of-the-art Grace Grego Maxwell Mental Health Unit there.
Recognizing her hard work, the Travis County Medical Society named her the 2017 Ruth M. Bain Young Physician of the Year. She has also earned the highest honors in her field’s professional organizations – Fellow of the American Psychiatric Association and Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry.
Dr. Krishna has published papers, presented research and led workshops at local, national, and international conferences. She has also appeared on many media outlets to promote public health awareness. She started her private practice in 2019 to provide excellent, patient centered, and collaborative care to children and families.